Form 4: National Healthcare Corp Director Exercises Stock Options
SEC Form 4 Filing
W. Andrew Adams, a director at National Healthcare Corp, exercised stock options on May 2, 2025, acquiring 7,500 shares of common stock.
Summary
- On May 2, 2025, W. Andrew Adams, a director of National Healthcare Corp (NHC), exercised options to purchase 7,500 shares of common stock at a price of $64.64 per share.
- This transaction was executed under the company's 2020 Omnibus Equity Incentive Plan.
- Following the transaction, Adams directly owns 269,572 shares of common stock through a revocable living trust and indirectly owns 35,407 shares through the Adams Family Foundation II where he serves as a trustee.
- Adams also holds options to purchase an additional 30,000 shares of common stock under various grants from 2021 to 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock option exercise. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Positives
- The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Stock option exercises are a common form of executive compensation in the healthcare industry. Monitoring these transactions provides insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in publicly traded healthcare companies like Brookdale Senior Living, LifePoint Health, and HCA Healthcare.
- The specific terms of option grants (exercise price, vesting schedule, expiration date) are typically benchmarked against industry peers to attract and retain talent.
Stakeholder Impact
- The exercise of stock options can have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/07/2020 | Date of the 2020 Omnibus Equity Incentive Plan grant. |
| 05/07/2021 | Date the 2020 Grant options became exercisable. |
| 05/06/2022 | Date the 2021 Grant options became exercisable. |
| 05/05/2023 | Date the 2022 Grant options became exercisable. |
| 05/04/2024 | Date the 2023 Grant options became exercisable. |
| 05/02/2025 | Date of the reported transaction (option exercise). |
| 05/06/2025 | Date of signature on the form. |
| 05/06/2025 | Expiration date of the 2020 Grant options. |
| 05/05/2026 | Expiration date of the 2021 Grant options. |
| 05/04/2027 | Expiration date of the 2022 Grant options. |
| 05/02/2028 | Expiration date of the 2023 Grant options. |
| 05/08/2029 | Expiration date of the 2024 Grant options. |
Keywords
stock options, director, exercise, National Healthcare Corp, NHC, Form 4, beneficial ownership, W. Andrew Adams
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.